Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life Study. - Farina L; Noto A; Aiello A; Motta M; Ferrario A; Moia R; Scarfò L; Deodato M; Merli M; Ljevar S; Pruneri G; Carniti C; et al. (Hematological oncology, 2026)